May 29 (Reuters) - Aroa Biosurgery Ltd ARX.AX:

• FY PRODUCT REVENUE NZD 84 MILLION

• FY ADJUSTED EBITDA NZD 4.2 MILLION

• FY PRODUCT GROSS MARGIN 86%

• FY ADJUSTED EBIT NZD -800 THOUSAND

• FY GROSS PROFIT NZD 72.6 MILLION

• FY ADJUSTED OPERATING EXPENSES NZD 74.5 MILLION

• TOTAL REVENUE GUIDANCE OF NZ$92-100 MILLION FOR FY26

• SEES FY NORMALISED EBITDA OF NZ$5-8 MILLION

Further company coverage: ARX.AX

((Reuters.Briefs@thomsonreuters.com;))